 ANDOVER, Mass., Sept. 26, 2022 GLOBE NEWSWIRE -- Oncorus, Inc. Nasdaq: ONCR, a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced that President and Chief Executive Officer, Theodore Ted Ashburn, M.D., Ph.D., will participate in a fireside chat at Chardans 6th Annual Genetic Medicines Conference on Monday, October 3, 2022 at 2:00 p.m. ET in New York, NY. 